Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intragastric pH Profile of Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic GERD Patients
NCT00410592Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Oct 2006; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00410592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410592.